OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Development of KEAP1-targeting PROTAC and its antioxidant properties: In vitro and in vivo
Se Yong Park, Raju Gurung, Jung Ho Hwang, et al.
Redox Biology (2023) Vol. 64, pp. 102783-102783
Open Access | Times Cited: 16
Se Yong Park, Raju Gurung, Jung Ho Hwang, et al.
Redox Biology (2023) Vol. 64, pp. 102783-102783
Open Access | Times Cited: 16
Showing 16 citing articles:
Thirty years of NRF2: advances and therapeutic challenges
Donna D. Zhang
Nature Reviews Drug Discovery (2025)
Closed Access | Times Cited: 3
Donna D. Zhang
Nature Reviews Drug Discovery (2025)
Closed Access | Times Cited: 3
Advances in developing noncovalent small molecules targeting Keap1
Marilia Barreca, Yuting Qin, M Cadot, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 12, pp. 103800-103800
Open Access | Times Cited: 16
Marilia Barreca, Yuting Qin, M Cadot, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 12, pp. 103800-103800
Open Access | Times Cited: 16
Deciphering Acetaminophen-Induced Hepatotoxicity: The Crucial Role of Transcription Factors like Nuclear Factor Erythroid 2-Related Factor 2 (NRF2) as Genetic Determinants of Susceptibility to Drug-Induced Liver Injury
Ankit P. Laddha, Hangyu Wu, José E. Manautou
Drug Metabolism and Disposition (2024) Vol. 52, Iss. 8, pp. 740-753
Open Access | Times Cited: 5
Ankit P. Laddha, Hangyu Wu, José E. Manautou
Drug Metabolism and Disposition (2024) Vol. 52, Iss. 8, pp. 740-753
Open Access | Times Cited: 5
Targeting kelch-like (KLHL) proteins: achievements, challenges and perspectives
Yangguo Zhou, Qiong Zhang, Ziquan Zhao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 269, pp. 116270-116270
Closed Access | Times Cited: 4
Yangguo Zhou, Qiong Zhang, Ziquan Zhao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 269, pp. 116270-116270
Closed Access | Times Cited: 4
Caffeic acid alleviates myocardial ischemia-reperfusion injury by directly targeting Keap1N532/M550 and promoting its degradation
Ying Zhang, Huan Lan, Wenjuan Zhai, et al.
Journal of Pharmaceutical Analysis (2025), pp. 101219-101219
Open Access
Ying Zhang, Huan Lan, Wenjuan Zhai, et al.
Journal of Pharmaceutical Analysis (2025), pp. 101219-101219
Open Access
Patenting perspective on Keap1 inhibitors (2019-2024)
Yue Luo, Wenlong Yang, Yuan Zhang, et al.
Expert Opinion on Therapeutic Patents (2025)
Closed Access
Yue Luo, Wenlong Yang, Yuan Zhang, et al.
Expert Opinion on Therapeutic Patents (2025)
Closed Access
Compound K-Enriched Korean Red Ginseng Prevents Lung Cancer Progression by Targeting Cancer Cells and Fibroblasts
Jung Ho Hwang, Se Yong Park, Ju‐Hee Kang, et al.
Journal of Ginseng Research (2025)
Open Access
Jung Ho Hwang, Se Yong Park, Ju‐Hee Kang, et al.
Journal of Ginseng Research (2025)
Open Access
Targeted Protein Degradation (TPD) for Immunotherapy: Understanding Proteolysis Targeting Chimera-Driven Ubiquitin-Proteasome Interactions
Rajamanikkam Kamaraj, Subhrojyoti Ghosh, Souvadra Das, et al.
Bioconjugate Chemistry (2024) Vol. 35, Iss. 8, pp. 1089-1115
Open Access | Times Cited: 3
Rajamanikkam Kamaraj, Subhrojyoti Ghosh, Souvadra Das, et al.
Bioconjugate Chemistry (2024) Vol. 35, Iss. 8, pp. 1089-1115
Open Access | Times Cited: 3
CRBN‐PROTACs in Cancer Therapy: From Mechanistic Insights to Clinical Applications
Riya Thapa, Asif Ahmad Bhat, Gaurav Gupta, et al.
Chemical Biology & Drug Design (2024) Vol. 104, Iss. 5
Open Access | Times Cited: 3
Riya Thapa, Asif Ahmad Bhat, Gaurav Gupta, et al.
Chemical Biology & Drug Design (2024) Vol. 104, Iss. 5
Open Access | Times Cited: 3
Structure-Guided Conformational Restriction Leading to High-Affinity, Selective, and Cell-Active Tetrahydroisoquinoline-Based Noncovalent Keap1-Nrf2 Inhibitors
Yuting Qin, Cecilie Poulsen, Dilip Narayanan, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 3
Yuting Qin, Cecilie Poulsen, Dilip Narayanan, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 3
Inhibition of Proliferation and Induction of Apoptosis in Prostatic Carcinoma DU145 Cells by Polysaccharides from Yunnan Rosa roxburghii Tratt
Ziyan Yang, Guiyuan Chen
Molecules (2024) Vol. 29, Iss. 7, pp. 1575-1575
Open Access | Times Cited: 2
Ziyan Yang, Guiyuan Chen
Molecules (2024) Vol. 29, Iss. 7, pp. 1575-1575
Open Access | Times Cited: 2
Multi-omics approach reveals dysregulated genes during hESCs neuronal differentiation exposure to paracetamol
Mari Spildrejorde, Athina Samara, Ankush Sharma, et al.
iScience (2023) Vol. 26, Iss. 10, pp. 107755-107755
Open Access | Times Cited: 6
Mari Spildrejorde, Athina Samara, Ankush Sharma, et al.
iScience (2023) Vol. 26, Iss. 10, pp. 107755-107755
Open Access | Times Cited: 6
Bivalent inhibitors of the BTB E3 ligase KEAP1 enable instant NRF2 activation to suppress acute inflammatory response
Mengchen Lu, Jianai Ji, Yifei Lv, et al.
Cell chemical biology (2023) Vol. 31, Iss. 6, pp. 1188-1202.e10
Closed Access | Times Cited: 5
Mengchen Lu, Jianai Ji, Yifei Lv, et al.
Cell chemical biology (2023) Vol. 31, Iss. 6, pp. 1188-1202.e10
Closed Access | Times Cited: 5
Direct degradation and stabilization of proteins: New horizons in treatment of nonalcoholic steatohepatitis
Yibing Wang, Jianan Zheng, Yun‐Ze Long, et al.
Biochemical Pharmacology (2023) Vol. 220, pp. 115989-115989
Closed Access | Times Cited: 2
Yibing Wang, Jianan Zheng, Yun‐Ze Long, et al.
Biochemical Pharmacology (2023) Vol. 220, pp. 115989-115989
Closed Access | Times Cited: 2
Loss of Ninjurin1 alleviates acetaminophen-induced liver injury via enhancing AMPKα-NRF2 pathway
Se Yong Park, Min Woo Kim, Ju-Hee Kang, et al.
Life Sciences (2024) Vol. 350, pp. 122782-122782
Closed Access
Se Yong Park, Min Woo Kim, Ju-Hee Kang, et al.
Life Sciences (2024) Vol. 350, pp. 122782-122782
Closed Access
PTGES3 proteolysis using the liposomal peptide-PROTAC approach
Shiwei Liu, Fukang Yuan, Hui Dong, et al.
Biology Direct (2024) Vol. 19, Iss. 1
Open Access
Shiwei Liu, Fukang Yuan, Hui Dong, et al.
Biology Direct (2024) Vol. 19, Iss. 1
Open Access
